Found: 6
Select item for more details and to access through your institution.
p21<sup>Waf1/Cip1/Sdi1</sup> induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53.
- Published in:
- Oncogene, 1999, v. 18, n. 18, p. 2789, doi. 10.1038/sj.onc.1202615
- By:
- Publication type:
- Article
Azacitidine in Lower‐Risk Myelodysplastic Syndromes: A Meta‐Analysis of Data from Prospective Studies.
- Published in:
- Oncologist, 2018, v. 23, n. 2, p. 159, doi. 10.1634/theoncologist.2017-0215
- By:
- Publication type:
- Article
Clinical Outcomes Associated with Bevacizumab-Containing Treatment of Metastatic Colorectal Cancer: The BRiTE Observational Cohort Study.
- Published in:
- Oncologist, 2009, v. 14, n. 9, p. 862, doi. 10.1634/theoncologist.2009-0071
- By:
- Publication type:
- Article
p53-Induced Growth Arrest Is Regulated by the Mitochondrial SirT3 Deacetylase.
- Published in:
- PLoS ONE, 2010, v. 5, n. 5, p. 1, doi. 10.1371/journal.pone.0010486
- By:
- Publication type:
- Article
Real-world analysis of the Celgene Global Drug Safety database: early discontinuation of lenalidomide in patients with myelodysplastic syndromes due to non-serious rash.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
- Published in:
- 2016
- By:
- Publication type:
- journal article